Literature DB >> 19216021

Leukocyte telomere dynamics and human hematopoietic stem cell kinetics during somatic growth.

Igor Sidorov1, Masayuki Kimura, Anatoli Yashin, Abraham Aviv.   

Abstract

OBJECTIVE: A central question in stem cell research is knowing the frequency of human hematopoietic stem cells (HSC) replication in vivo.
MATERIALS AND METHODS: We have constructed a model that characterizes HSC kinetics and the relative sizes of the hematopoietic progenitor cell (HPC) and HSC pools from birth onward. The model capitalizes on leukocyte telomere length (LTL) data and body weight-gain charts from birth to the age of 20 years. The core premise of the model is that during human growth, LTL dynamics (birth LTL and age-dependent LTL shortening afterward) chronicle the expansions of the HSC and HPC pools.
RESULTS: The model estimates that by the end of the first year of life, HSC have replicated approximately 17 times and they replicate approximately 2.5 times/year between the ages of 3 and 13 years. Subsequently, HSC replication slows considerably. In adults HSC replicate at a rate of approximately 0.6 times/year. In addition, the model predicts that newborns with small birth weight would have shorter LTL as adults and that women would have longer LTL than men.
CONCLUSION: Our findings will be useful in bone marrow transplantations and might explain a body of clinical observations related to LTL distribution in the general population.

Entities:  

Mesh:

Year:  2009        PMID: 19216021     DOI: 10.1016/j.exphem.2008.11.009

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  66 in total

1.  Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia.

Authors:  Andrii I Rozhok; Jennifer L Salstrom; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

2.  Leukocyte telomere length: the telomere tale continues.

Authors:  Abraham Aviv
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

Review 3.  Telomeres, atherosclerosis, and the hemothelium: the longer view.

Authors:  Abraham Aviv; Daniel Levy
Journal:  Annu Rev Med       Date:  2011-10-17       Impact factor: 13.739

4.  Telomere dynamics in rhesus monkeys: no apparent effect of caloric restriction.

Authors:  Daniel L Smith; Julie A Mattison; Renee A Desmond; Jeffrey P Gardner; Masayuki Kimura; George S Roth; Donald K Ingram; David B Allison; Abraham Aviv
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-22       Impact factor: 6.053

5.  Telomere-associated polymorphisms correlate with cardiovascular disease mortality in Caucasian women: the Cardiovascular Health Study.

Authors:  Andrea N Burnett-Hartman; Annette L Fitzpatrick; Richard A Kronmal; Bruce M Psaty; Nancy S Jenny; Josh C Bis; Russ P Tracy; Masayuki Kimura; Abraham Aviv
Journal:  Mech Ageing Dev       Date:  2012-03-16       Impact factor: 5.432

Review 6.  Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?

Authors:  Jason L Sanders; Anne B Newman
Journal:  Epidemiol Rev       Date:  2013-01-09       Impact factor: 6.222

7.  Maternal pro-inflammatory state during pregnancy and newborn leukocyte telomere length: A prospective investigation.

Authors:  Claudia Lazarides; Elissa S Epel; Jue Lin; Elizabeth H Blackburn; Manuel C Voelkle; Claudia Buss; Hyagriv N Simhan; Pathik D Wadhwa; Sonja Entringer
Journal:  Brain Behav Immun       Date:  2019-04-08       Impact factor: 7.217

8.  The replication rate of human hematopoietic stem cells in vivo.

Authors:  Sandra N Catlin; Lambert Busque; Rosemary E Gale; Peter Guttorp; Janis L Abkowitz
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

9.  On the correlation between telomere shortening rate and life span.

Authors:  Ion Udroiu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

Review 10.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.